Macrophage inflammatory protein-1β: A novel prognostic biomarker in atherosclerosis?

Cardiology

Volumn 121, Issue 3, 2012, Pages 149-151

  Vistnes, Maria ^a  

^a UNIVERSITY OF OSLO   (Norway)

Author keywords

[No Author keywords available]

Indexed keywords

C REACTIVE PROTEIN; EOTAXIN; FIBRINOGEN; INTERLEUKIN 1; INTERLEUKIN 6; MACROPHAGE INFLAMMATORY PROTEIN 1BETA; RANTES; TUMOR NECROSIS FACTOR ALPHA;

ACUTE HEART INFARCTION; ARTERY LESION; ARTERY WALL; ATHEROMA; ATHEROSCLEROSIS; CARDIAC PATIENT; CARDIOVASCULAR DISEASE; CELL MIGRATION; CORONARY ARTERY; CORONARY ARTERY DISEASE; HUMAN; IMMUNOCOMPETENT CELL; META ANALYSIS (TOPIC); MONOCYTE; NOTE; PATHOPHYSIOLOGY; PRIORITY JOURNAL; PROGNOSIS; RISK ASSESSMENT; RISK FACTOR;

BIOLOGICAL MARKERS; CHEMOKINE CCL4; CORONARY ARTERY DISEASE; FIBRINOGEN; HUMANS; PROGNOSIS;

EID: 84858712517     PISSN: 00086312     EISSN: 14219751     Source Type: Journal    
DOI: 10.1159/000336484     Document Type: Note

References (20)

1. Ross R: Atherosclerosis - An inflammatory disease. N Engl J Med 1999; 340: 115-126. (Pubitemid 29054847)
2. Merhi-Soussi F, Kwak BR, Magne D, Chadjichristos C, Berti M, Pelli G, James RW, Mach F, Gabay C: Interleukin-1 plays a major role in vascular inflammation and atherosclerosis in male apolipoprotein Eknockout mice. Cardiovasc Res 2005; 66: 583-593. (Pubitemid 40725770)
3. Danesh J, Kaptoge S, Mann AG, Sarwar N, Wood A, Angleman SB, Wensley F, Higgins JPT, Lennon L, Eiriksdottir G, Rumley A, Whincup PH, Lowe GDO, Gudnason V: Long-term interleukin-6 levels and subsequent risk of coronary heart disease: Two new prospective studies and a systematic review. PLoS Med 2008; 5:e78.
4. McKellar GE, McCarey DW, Sattar N, Mc-Innes IB: Role for TNF in atherosclerosis? Lessons from autoimmune disease. Nat Rev Cardiol 2009; 6: 410-417.
5. Libby P, Ridker PM, Hansson GK, Leducq Transatlantic Network on Atherothrombosis: Inflammation in atherosclerosis: From pathophysiology to practice. J Am Coll Cardiol 2009; 54: 2129-2138.
6. Ridker PM, Cannon CP, Morrow D, Rifai N, Rose LM, McCabe CH, Pfeffer MA, Braunwald E: C-reactive protein levels and outcomes after statin therapy. N Engl J Med 2005; 352: 20-28. (Pubitemid 40075677)
7. Charo IF, Taub R: Anti-inflammatory therapeutics for the treatment of atherosclerosis. Nat Rev Drug Discov 2011; 10: 365-376.
8. Charo IF, Ransohoff RM: The many roles of chemokines and chemokine receptors in inflammation. N Engl J Med 2006; 354: 610-621. (Pubitemid 43209108)
9. Aukrust P, Halvorsen B, Yndestad A, Ueland T, øie E, Otterdal K, Gullestad L, Damås JK.: Chemokines and cardiovascular risk. Arterioscler Thromb Vasc Biol 2008; 28: 1909-1919.
10. Xu F, Lv S, Chen Y, Song X, Jin Z, Yuan F, Zhou Y, Li H: Macrophage inflammatory protein-1 - And fibrinogen are synergistic predictive markers of prognosis of intermediate coronary artery lesions. Cardiology 2012;121:12-19.
11. Schecter AD, Calderon TM, Berman AB, McManus CM, Fallon JT, Rossikhina M, Zhao W, Christ G, Berman JW, Taubman MB: Human vascular smooth muscle cells possess functional CCR5. J Biol Chem 2000; 275: 5466-5471. (Pubitemid 30115180)
12. Cagnin S, Biscuola M, Patuzzo C, Trabetti E, Pasquali A, Laveder P, Faggian G, Iafrancesco M, Mazzucco A, Pignatti PF, Lanfranchi G: Reconstruction and functional analysis of altered molecular pathways in human atherosclerotic arteries. BMC Genomics 2009; 10: 13.
13. Jones KL, Maguire JJ, Davenport AP: Chemokine receptor CCR5: From AIDS to atherosclerosis. Br J Pharmacol 2011; 162: 1453-1469.
14. Rizzo M, Corrado E, Coppola G, Muratori I, Novo G, Novo S: Prediction of cardio- and cerebro-vascular events in patients with subclinical carotid atherosclerosis and low HDL-cholesterol. Atherosclerosis 2008; 200: 389-395.
15. Sabeti S, Exner M, Mlekusch W, Amighi J, Quehenberger P, Rumpold H, Maurer G, Minar E, Wagner O, Schillinger M: Prognostic impact of fibrinogen in carotid atherosclerosis. Stroke 2005; 36: 1400-1404.
16. Fibrinogen SC: Plasma fibrinogen level and the risk of major cardiovascular diseases and nonvascular mortality. JAMA 2005; 294: 1799-1809.
17. Corrado E, Rizzo M, Tantillo R, Muratori I, Bonura F, Vitale G, Novo S: Markers of inflammation and infection influence the outcome of patients with baseline asymptomatic carotid lesions. Stroke 2006; 37: 482-486. (Pubitemid 43732010)
18. Pearson TA, Mensah GA, Alexander RW, Anderson JL, Cannon RO, Criqui M, Fadl YY, Fortmann SP, Hong Y, Myers GL, Rifai N, Smith SC, Taubert K, Tracy RP, Vinicor F: Markers of inflammation and cardiovascular disease. Circulation 2003; 107: 499-511.
19. Heffron SP, Parastatidis I, Cuchel M, Wolfe ML, Tadesse MG, Mohler ER III, Ischiropoulos H, Rader DJ, Reilly MP: Inflammation induces fibrinogen nitration in experimental human endotoxemia. Free Radic Biol Med 2009; 47: 1140-1146.
20. Packard RRS, Libby P: Inflammation in atherosclerosis: From vascular biology to biomarker discovery and risk prediction. Clin Chem 2008; 54: 24-38. (Pubitemid 351182593)